|
|
 |
|
Viewing report
|
|
|
|
OTC Obesity in Portugal
Euromonitor International, March 2010, Pages: 32
Value sales of OTC obesity in Portugal, comprised exclusively of the Alli brand, represented EUR2 million in 2009. In fact, Alli the active ingredient of which is Oristat, was switched to be available in pharmacies and parapharmacies during the review period. Consumer receptivity to this new OTC medicine was very good, as to lose weight Portuguese consumers are willing to try all types of novelties, particularly those which benefit from word-of-mouth recommendations.
The OTC Obesity Products in Portugal report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage:
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Consumer Health industry;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
.
Customers who bought this item also bought
Slimming Products in Portugal
Wound Treatments in Portugal
Vitamins and Dietary Supplements in Portugal
Sports Nutrition in Portugal
Weight Management in Portugal
Digestive Remedies in Portugal
Analgesics in Brazil
Digestive Remedies in Brazil
Vitamins and Dietary Supplements in Spain
Vitamins and Dietary Supplements - Brazil
|
|
|
|
